HAS opinions and decisions
La fiche de bon usage du médicament intitulée « Bon usage des médicaments utilisés dans les formes très actives de sclérose en plaques récurrente », ci-jointe, est adoptée.
See also
Évaluation des médicaments
08/10/2019
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
H6MnREzLtLFFKtty
